Vol. 15 No. 4 (2014)

Vol. 15 No. 4 (2014)

Published: 2014-12-23

The trend of pharmaceutical expenditure in Italy: from the report OsMed 2013 to the monitoring 2014

Mario Eandi

97-98
- HTML
- PDF

Cost‑effectiveness analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients

Lorenzo Pradelli, Mario Calandriello, Roberto Di Virgilio, Marco Bellone, Marco Tubaro

101-112
- HTML
- PDF
Venous tromboembolism treatment: budget impact analysis of rivaroxaban in Italy

Daniela Paola Roggeri, Alessandro Roggeri, Vittorio Pengo

113-127
- HTML
- PDF
Economic impact of the use of Hyalubrix® in the treatment of hip osteoarthritis in Italy

Alberto Migliore, Andrea Belisari, Lucia S. D'Angiolella, Emanuele Bizzi, Umberto Massafra, Prisco Piscitelli, Lorenzo Giovanni Mantovani

139-146
- HTML
- PDF
How do European patients feel about the listening skills of primary care physicians? Results from the EUprimecare Project

Carlos Alberto Sánchez Piedra, Sonia García-Pérez, Francisco Javier Prado-Galbarro, Antonio Sarría-Santamera

147-153
- HTML
- PDF
Pharmacoeconomic aspects related to the 13-valent pneumococcal conjugate vaccine: preliminary analysis of the data from the ASL of Viterbo

Silvia Dari, Flavia Verginelli, Silvia Aquilani

155-159
- HTML
- PDF

Cost-effectiveness of intravitreal therapy in Age-Related Macular Degeneration

Piergiorgio Neri, Ilir Arapi, Chiara Maria Eandi, Vittorio Pirani, Cesare Mariotti, Alfonso Giovannini

129-138
- HTML
- PDF